{"id":69022,"date":"2026-03-13T12:06:16","date_gmt":"2026-03-13T12:06:16","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69022"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"igf-1-lr3","status":"publish","type":"product","link":"https:\/\/medsbase.com\/de\/product\/igf-1-lr3\/","title":{"rendered":"IGF-1 LR3"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Kurze Antwort \u2014 Was ist IGF-1 LR3?<\/h3>\n<p style=\"margin: 0;\"><strong>IGF-1 LR3<\/strong> is a peptide supplied as a lyophilized powder for reconstitution. The information on this page describes published preclinical and early clinical literature; it is not medical advice or dosing guidance. Read our linked guide for the complete evidence summary.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Was Sie bei MedsBase erhalten:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/de\/reviews\/\">Kundenbewertungen<\/a><\/div>\n<h2 data-section-id=\"1v2vk1x\">IGF-1 LR3 Peptid<\/h2>\n<p><span style=\"font-size: 120%;\">IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a modified analog of insulin-like growth factor-1 designed for studies involving cellular growth signaling, anabolic pathways, and metabolic regulation. This extended variant contains structural modifications that increase its stability and prolong its biological activity compared to standard IGF-1, allowing users to study sustained IGF-1 receptor activation in clinical models. IGF-1 LR3 interacts with IGF-1 receptors involved in cellular proliferation, protein synthesis, and nutrient utilization. Due to its extended half-life and reduced binding to IGF-binding proteins, it provides a useful framework for examining mechanisms related to tissue growth, metabolic efficiency, and cellular repair processes. Studies suggest IGF-1 LR3 may support pathways associated with muscle cell growth, enhanced protein synthesis, improved recovery from physical stress, and regulation of glucose metabolism. Its activity also makes it valuable for investigating regenerative signaling, cellular differentiation, and anabolic responses in controlled experimental environments.<\/span><\/p>\n<hr \/>\n<h2 data-section-id=\"1bovg99\"><strong>Produkt\u00fcbersicht<\/strong><\/h2>\n<p>IGF-1 LR3 is a synthetic peptide classified as a modified insulin-like growth factor analog engineered to extend biological stability and receptor interaction duration in clinical models. With the molecular formula C400H625N111O115S9 and molar mass of 9117.60 g\/mol, IGF-1 LR3 peptide is widely studied in experimental clinical settings focusing on cellular growth pathways and metabolic signaling. Each vial contains 0.1 mg or 1 mg of lyophilized IGF-1 LR3 supplied in high purity lyophilized form designed for clinical investigation. The peptide is valued for its structural modifications that reduce binding to IGF-binding proteins and prolong receptor activity in controlled studies environments. <\/p>\n<hr \/>\n<h2 data-section-id=\"engqt1\"><strong>Published Evidence<\/strong><\/h2>\n<p>IGF-1 LR3 peptide is commonly utilized in clinical investigation of cellular growth signaling and anabolic pathway activity. In vitro studies frequently examine IGF-1 receptor activation and downstream intracellular signaling mechanisms associated with protein synthesis and nutrient utilization. Pre-clinical models use IGF-1 LR3 for studies to analyze cellular proliferation patterns and metabolic regulation responses. Users also explore tissue culture environments where growth factor signaling can be measured under controlled experimental conditions. IGF-1 LR3 supports investigations into cellular differentiation, metabolic signaling cascades, and anabolic response pathways. These applications provide valuable insight into mechanisms associated with growth signaling networks in experimental clinical settings. <\/p>\n<hr \/>\n<h2 data-section-id=\"g6iwef\"><strong>Rekonstitution und Handhabung<\/strong><\/h2>\n<p>Lyophilized IGF-1 LR3 should be reconstituted using bacteriostatic water in a sterile clinical environment. Users should apply strict aseptic technique when introducing solvent into the vial to preserve peptide integrity and experimental accuracy. Inject the solution slowly along the inner vial wall to prevent peptide destabilization. Avoid shaking the vial; instead, gently swirl until the lyophilized IGF-1 LR3 powder is fully dissolved. After reconstitution, store the solution at 2\u20138\u00b0C and maintain it in a controlled clinical environment. Proper handling procedures help preserve the stability of IGF-1 LR3 peptide for consistent experimental outcomes. <\/p>\n<hr \/>\n<h2 data-section-id=\"evp82x\"><strong>Wirkmechanismus<\/strong><\/h2>\n<p>IGF-1 LR3 peptide interacts primarily with insulin-like growth factor receptors involved in cellular growth and metabolic signaling. In experimental clinical settings, this interaction stimulates intracellular pathways related to protein synthesis, nutrient uptake, and cellular proliferation markers. The structural modification of IGF-1 LR3 reduces affinity for IGF-binding proteins, allowing sustained receptor activation in clinical models. In vitro studies indicate that this prolonged signaling may influence pathways related to anabolic cellular responses. Users use IGF-1 LR3 for studies to explore receptor activation dynamics and downstream molecular cascades. These mechanisms provide insight into regulatory processes associated with cellular growth and metabolic adaptation. <\/p>\n<hr \/>\n<h2 data-section-id=\"1dcajhc\"><strong>Dosierungsrichtlinien<\/strong><\/h2>\n<p> Dosing ranges reported in published experimental literature vary depending on the model system and assay design. In vitro investigations often use IGF-1 LR3 peptide concentrations measured in nanomolar to micromolar ranges depending on cell line sensitivity. Pre-clinical experimental models may adjust concentration parameters to evaluate receptor signaling responses and metabolic activity markers. Users should determine optimal concentration ranges through preliminary assay validation. Lyophilized IGF-1 LR3 should be prepared and measured carefully to maintain experimental consistency. <\/p>\n<hr \/>\n<h2 data-section-id=\"1pbh8fc\"><strong>Potential Benefits<\/strong><\/h2>\n<ul>\n<li data-section-id=\"1pm95a8\">Zellul\u00e4re Reaktionsmarker im Zusammenhang mit Wachstumsfaktor-Signal\u00fcbertragung<\/li>\n<li data-section-id=\"1r9cuo2\">Gewebekulturbeobachtungen der Aktivierung anaboler Signalwege<\/li>\n<li data-section-id=\"1fytcje\">Stabilit\u00e4t der Signalaktivit\u00e4t in simulierten metabolischen Umgebungen<\/li>\n<li data-section-id=\"1k1mv77\">Potenzial der Rezeptorinteraktion mit IGF-1-Signalwegen<\/li>\n<li data-section-id=\"1c1eyxc\">Angiogene und proliferative Signalwegmarker<\/li>\n<\/ul>\n<hr \/>\n<h2 data-section-id=\"1tir0k8\"><strong>Experimentelle Beobachtungen<\/strong><\/h2>\n<p>Clinical investigations involving IGF-1 LR3 peptide often observe enhanced signaling activity within IGF-1 receptor pathways in controlled experimental conditions. In vitro cell culture models demonstrate measurable changes in cellular proliferation markers and protein synthesis indicators. Users studying metabolic signaling frequently document changes in nutrient uptake pathways when IGF-1 LR3 is introduced to experimental systems. Pre-clinical models have also examined IGF-1 LR3 in relation to differentiation signaling and cellular development patterns. These observations contribute to understanding how sustained receptor activation influences complex cellular networks. IGF-1 LR3 therefore provides a reproducible framework for studying anabolic signaling pathways in experimental clinical settings. <\/p>\n<hr \/>\n<h2 data-section-id=\"1pt12ft\"><strong>Considerations<\/strong><\/h2>\n<p>Users working with IGF-1 LR3 should ensure strict clinical protocols are followed to maintain peptide stability and experimental validity. Environmental conditions such as temperature, solvent compatibility, and assay sensitivity can influence peptide behavior in vitro studies. Careful calibration of concentrations is recommended before initiating extended clinical investigation. IGF-1 LR3 peptide may interact with other growth factors or signaling molecules within complex experimental systems. Documentation of handling procedures and experimental parameters is essential for reproducibility. All work involving IGF-1 LR3 must remain within approved studies and clinical use guidelines. <\/p>\n<hr \/>\n<h2 data-section-id=\"y0g1yb\"><strong>Sicherheitshinweis<\/strong><\/h2>\n<p>IGF-1 LR3 peptide should be handled using standard clinical safety practices including protective equipment and appropriate containment procedures. Users must ensure that the compound is stored, handled, and disposed of according to institutional clinical safety guidelines. Direct exposure should be minimized and clinical-grade handling tools should be used when preparing experimental solutions. This peptide is intended exclusively for scientific investigation and must not be used outside of controlled studies environments. The information provided is for educational and scientific reference and should not be interpreted as medical advice or as a recommendation for any form of administration. Users should follow all applicable regulations and institutional guidelines when handling this material. <\/p>\n<hr \/>\n<h2 data-section-id=\"1xqr4ds\"><strong>Lagerungshinweise<\/strong><\/h2>\n<p>Store lyophilized IGF-1 LR3 at \u221220\u00b0C for long-term storage to maintain peptide stability and structural integrity. For short-term clinical use, the peptide may be stored at 2\u20138\u00b0C under controlled refrigeration conditions. Protect IGF-1 LR3 from direct light exposure to prevent degradation of the peptide structure. Avoid repeated freeze-thaw cycles as these may reduce peptide stability and affect experimental reproducibility. When stored properly, IGF-1 LR3 maintains a shelf life of approximately 36 months. Proper storage ensures reliable clinical performance of lyophilized IGF-1 LR3 for studies. <\/p>\n<h2><strong>Reinheit &amp; Qualit\u00e4t<\/strong><\/h2>\n<p>All IGF-1 LR3 vials stocked by MedsBase are supplied at 99%+ HPLC purity in lyophilized form. A certificate of analysis (COA) is available on request \u2014 message our support team after placing your order and we will forward the batch-specific COA for the vials you received. It is sold. Some peptides in this class have been used in early-phase clinical trials but no major regulator has issued a marketing authorization for the indications discussed in the popular literature. <\/p>\n<h3>Wie wird IGF-1 LR3 rekonstituiert?<\/h3>\n<p>Lyophilisierte Peptide werden typischerweise mit bakterienstatischem Wasser oder sterilem Wasser zur Injektion (BWFI \/ SWFI) in einer f\u00fcr die geplante Dosis geeigneten Konzentration rekonstituiert. Geben Sie das Verd\u00fcnnungsmittel langsam an der Innenwand des Fl\u00e4schchens hinzu \u2014 spritzen Sie den Strahl nicht direkt in das Pulver oder sch\u00fctteln Sie es kr\u00e4ftig, da beides das Peptid denaturiert. Schwenken Sie das Fl\u00e4schchen vorsichtig, bis es vollst\u00e4ndig gel\u00f6st ist. Rekonstituierte Peptide werden typischerweise gek\u00fchlt bei 2\u20138\u00b0C gelagert. <\/p>\n<h3>Wie sollte IGF-1 LR3 gelagert werden?<\/h3>\n<p>Lyophilisierte Fl\u00e4schchen sind bei Lagerung bei \u221220\u00b0C oder gek\u00fchlt bei 2\u20138\u00b0C, fern von direktem Licht, \u00fcber l\u00e4ngere Zeit stabil. Nach der Rekonstitution sind die meisten Peptide je nach Puffer und spezifischem Peptid 14\u201330 Tage im K\u00fchlschrank haltbar. Lesen Sie stets das beiliegende Analysezertifikat f\u00fcr die vom Lieferanten empfohlenen Lagerungs- und Stabilit\u00e4tsdaten. <\/p>\n<h3>What does the published literature shows?<\/h3>\n<p>The published literature on IGF-1 LR3 is summarized in our linked guide. We separate preclinical (rodent \/ cell-culture) data, where it is consistent and reproducible, from clinical-trial data, where evidence is typically thinner. We also flag where popular online claims outrun the published record. <\/p>\n<h3>Ist IGF-1 LR3 legal international zu bestellen?<\/h3>\n<p>Peptides occupy an ambiguous regulatory space. Importation rules vary by country and have changed in several jurisdictions over the past few years. It is the buyer\u2019s responsibility to confirm import legality in their destination country before ordering. MedsBase ships peptides worldwide via our dedicated peptide courier; orders that contravene the destination country\u2019s import rules may be detained at customs. <\/p>\n<h3>Was ist die Halbwertszeit von IGF-1 LR3?<\/h3>\n<p>IGF-1 LR3 has an estimated half-life of 20\u201330 hours in preclinical studies \u2014 dramatically longer than native IGF-1 (approximately 6\u20138 hours). The LR3 modification reduces IGF-binding protein (IGFBP) affinity, increasing the free (bioavailable) IGF-1 fraction in circulation and extending active duration. <\/p>\n<h3>Wie unterscheidet sich IGF-1 LR3 von nativem IGF-1?<\/h3>\n<p>IGF-1 LR3 is an 83-amino-acid analog of the naturally occurring 70-amino-acid IGF-1. The LR3 modification significantly reduces binding to the six known IGF-binding proteins (IGFBPs), which normally sequester ~98% of endogenous IGF-1. This results in a substantially higher free-peptide fraction and extended half-life, making IGF-1 LR3 a preferred compound in studies requiring prolonged IGF-1 receptor activation. <\/p>\n<h3>Kann ich IGF-1 LR3 zusammen mit anderen Peptiden bestellen?<\/h3>\n<p>Yes. Peptide orders are bundled and ship together via our peptide-only courier service. Lyophilized vials are protective for the duration of standard international transit. See our peptide category page for the full stocked range and the \u201cBest Peptides for Recovery\u201d comparison guide for stacking considerations from the published literature. <\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">IGF-1 LR3-Protokolle beinhalten h\u00e4ufig BPC-157 und TB-500 zur Unterst\u00fctzung von Gelenken und Sehnen w\u00e4hrend der IGF-getriebenen anabolen Phase; unser <a href=\"\/de\/peptide-healing-stack\/\">Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + bakteriostatischem Wasser)<\/a> B\u00fcndel enth\u00e4lt sowohl lyophilisierte Fl\u00e4schchen als auch Rekonstitutionswasser zum Peptid-Versandpreis von $0.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/de\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/de\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/de\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Selektiver Ghrelin-Agonist \u2014 sauberer GH-Puls ohne Cortisol\/Prolaktin<\/li>\n<li><a href=\"\/de\/cjc-1295-with-dac\/\"><strong>CJC-1295 mit DAC<\/strong><\/a> \u2014 GHRH-Analogon mit verl\u00e4ngerter Halbwertszeit<\/li>\n<li><a href=\"\/de\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Weiterf\u00fchrende Literatur<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lesen Sie unseren vollst\u00e4ndigen evidenzbasierten Leitfaden: <a href=\"https:\/\/medsbase.com\/de\/igf-1-lr3-peptide-guide\/\"><strong>IGF-1 LR3 \u2014 seri\u00f6se Wissenschaft, Dosierung &amp; Sicherheit<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Jede Bestellung ist durch unsere <a href=\"https:\/\/medsbase.com\/de\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> abgedeckt \u2014 wenn Ihr Paket nicht innerhalb von 20 Werktagen ankommt, versenden wir es erneut.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Spezifikation<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS-Nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">946870-92-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekularformel<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>400<\/sub>H<sub>625<\/sub>N<sub>111<\/sub>O<sub>120<\/sub>S<sub>9<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekulargewicht<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~9117.4 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenz<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Long R<sup>3<\/sup> IGF-1 (83 Aminos\u00e4uren; N-terminales MFPAMPLSSLFVNGPRTLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilisat (oder wie geliefert)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Reinheit<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC-best\u00e4tigt, COA auf Anfrage)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Lagerung<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilisat: 2\u20138 \u00b0C (K\u00fchlschrank) f\u00fcr Arbeitsvorrat; \u221220 \u00b0C zur Langzeitlagerung unge\u00f6ffneter Fl\u00e4schchen. Rekonstituierte L\u00f6sung: 2\u20138 \u00b0C, innerhalb von ~30 Tagen verbrauchen. Vermeiden Sie starkes Sch\u00fctteln; gro\u00dfe Peptide denaturieren durch Ersch\u00fctterung. Einfrieren und Auftauen der rekonstituierten L\u00f6sung vermeiden.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>L\u00f6slichkeit<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakteriostatisches Wasser (empfohlen) oder steriles Wasser f\u00fcr k\u00fcrzere Anwendungszeitr\u00e4ume<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Unterst\u00fctzt das Zellwachstum<br \/>\n\u2705 F\u00f6rdert die Proteinsynthese<br \/>\n\u2705 F\u00f6rdert die metabolische Signal\u00fcbertragung<br \/>\n\u2705 Verbessert die Geweberegeneration<br \/>\n\u2705 Verbessert die zellul\u00e4re Reparatur<\/p>\n<p><strong>IGF-1 LR3<\/strong> enth\u00e4lt synthetische Peptidverbindung.<\/p>","protected":false},"featured_media":70960,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5474],"class_list":["post-69022","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-igf-1-lr3","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product\/69022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/comments?post=69022"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media\/70960"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media?parent=69022"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_brand?post=69022"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_cat?post=69022"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_tag?post=69022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}